Literature DB >> 25302136

Secreted HoxA3 Promotes Epidermal Proliferation and Angiogenesis in Genetically Modified Three-Dimensional Composite Skin Constructs.

Jennifer H Kuo1, Ileana Cuevas2, Amy Chen2, Ashley Dunn2, Mauricio Kuri2, Nancy Boudreau2.   

Abstract

Objective: Homeobox (HOX) transcription factors coordinate gene expression in wound repair and angiogenesis. Previous studies have shown that gene transfer of HoxA3 to wounds of diabetic mice accelerates wound healing, increasing angiogenesis and keratinocyte migration. In this study, we examined whether HoxA3 can also improve angiogenesis, epidermal integrity, and viability of composite skin grafts. Approach: To determine the effects of HoxA3 on composite skin grafts, we constructed bilayered composite grafts incorporating fibroblasts engineered to constitutively secrete HoxA3. We then transplanted these composite grafts in vivo.
Results: The composite grafts produced a stratified epidermal layer after seventeen days in culture and following transplantation in vivo, these grafts exhibit normal epidermal differentiation and reduced contraction compared to controls. In addition, HoxA3 grafts showed increased angiogenesis. Quantitative polymerase chain reaction (PCR) analyses of HoxA3 graft tissue reveal an increase in the downstream HoxA3 target genes MMP-14 and uPAR expression, as well as a reduction in CCL-2 and CxCl-12. Innovation: Expression of secreted HoxA3 in composite grafts represents a comprehensive approach that targets both keratinocytes and endothelial cells to promote epidermal proliferation and angiogenesis.
Conclusion: Secreted HoxA3 improves angiogenesis, reduces expression of inflammatory mediators, and prolongs composite skin graft integrity.

Entities:  

Year:  2014        PMID: 25302136      PMCID: PMC4183908          DOI: 10.1089/wound.2013.0474

Source DB:  PubMed          Journal:  Adv Wound Care (New Rochelle)        ISSN: 2162-1918            Impact factor:   4.730


  30 in total

Review 1.  Homeoprotein intercellular transfer, the hidden face of cell-penetrating peptides.

Authors:  Alain Prochiantz
Journal:  Methods Mol Biol       Date:  2011

2.  The healing of full-thickness burns treated by using plasmid DNA encoding VEGF-165 activated collagen-chitosan dermal equivalents.

Authors:  Rui Guo; Shaojun Xu; Lie Ma; Aibin Huang; Changyou Gao
Journal:  Biomaterials       Date:  2010-11-10       Impact factor: 12.479

3.  A role for Hox A5 in regulating angiogenesis and vascular patterning.

Authors:  Kim Rhoads; Gemma Arderiu; Aubri Charboneau; Scott L Hansen; William Hoffman; Nancy Boudreau
Journal:  Lymphat Res Biol       Date:  2005       Impact factor: 2.589

Review 4.  Apligraf treatment of venous ulcers and other chronic wounds.

Authors:  V Falanga
Journal:  J Dermatol       Date:  1998-12       Impact factor: 4.005

5.  Bioengineered skin constructs and their use in wound healing.

Authors:  Tamara Lazic; Vincent Falanga
Journal:  Plast Reconstr Surg       Date:  2011-01       Impact factor: 4.730

6.  Fibroblasts from chronic wounds show altered TGF-beta-signaling and decreased TGF-beta Type II receptor expression.

Authors:  Byung-Chul Kim; Heung Tae Kim; Seok Hee Park; Ji-Sun Cha; Tatyana Yufit; Seong-Jin Kim; Vincent Falanga
Journal:  J Cell Physiol       Date:  2003-06       Impact factor: 6.384

7.  HOXA3 induces cell migration in endothelial and epithelial cells promoting angiogenesis and wound repair.

Authors:  Kimberly A Mace; Scott L Hansen; Connie Myers; David M Young; Nancy Boudreau
Journal:  J Cell Sci       Date:  2005-05-24       Impact factor: 5.285

8.  Utilization of living bilayered cell therapy (Apligraf) for heel ulcers.

Authors:  Jeff Karr
Journal:  Adv Skin Wound Care       Date:  2008-06       Impact factor: 2.347

9.  Induction of the angiogenic phenotype by Hox D3.

Authors:  N Boudreau; C Andrews; A Srebrow; A Ravanpay; D A Cheresh
Journal:  J Cell Biol       Date:  1997-10-06       Impact factor: 10.539

10.  HOXA3 modulates injury-induced mobilization and recruitment of bone marrow-derived cells.

Authors:  Kimberly A Mace; Terry E Restivo; John L Rinn; Agnes C Paquet; Howard Y Chang; David M Young; Nancy J Boudreau
Journal:  Stem Cells       Date:  2009-07       Impact factor: 6.277

View more
  1 in total

1.  ABCB5+ dermal mesenchymal stromal cells with favorable skin homing and local immunomodulation for recessive dystrophic epidermolysis bullosa treatment.

Authors:  Julia Riedl; Michael Pickett-Leonard; Cindy Eide; Mark Andreas Kluth; Christoph Ganss; Natasha Y Frank; Markus H Frank; Christen L Ebens; Jakub Tolar
Journal:  Stem Cells       Date:  2021-03-01       Impact factor: 5.845

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.